... valid. The patents cover antibodies that can help prevent cholesterol levels from spiking. Paris-based Sanofi and Tarrytown, New York-based Regeneron have vowed to appeal the jury's finding that Amgen's patents are valid and properly describe the ...
http://ift.tt/2iK1hu0
No comments:
Post a Comment